جستجوی استاد راهنمای دانشگاهی

Min Huمشاهده پروفایل

استادیار

• Health Economics
• Applied Microeconomics
• Labour Economics
• +۷ مورد دیگر

Min Hu is an Assistant Professor in the Department of Economics, Philosophy, and Political Science at the University of British Columbia, Okanagan Campus. He holds an adjunct position at Dalhousie University's School of Health Administration. His primary research focuses on Health Economics, Applied Microeconomics, and Labour Economics, with an emphasis on vulnerable populations in Canada, Indigenous health, income inequalities, and cancer economics. He teaches courses in Microeconomics, Health Economics, and Statistics. Education: PhD in Economics (2019), Dalhousie University; Postdoctoral Fellowship in Health Economics (2019–2020), Dalhousie University. Previous degrees include an M.A. (2014–2016) and B.A. in Economics from Dalhousie University. Research interests include the socio-economic determinants of health disparities, particularly among Indigenous peoples and immigrants, and the economic impacts of cancer-related policies. He employs applied econometric methods to analyze labor market outcomes and social policy effectiveness. His recent articles explore sustainable biomass utilization, energy policies, and environmental engineering innovations. Key themes include biomass supply chain optimization, CO₂ reduction strategies, and waste-to-energy technologies. Scientific Awards: Recipient of SSHRC New Frontiers Grant (2023–2026), CIHR Team Grant (2024–2026), and multiple UBC startup grants. His work is supported by SSHRC, CRDCN, and Indigenous Services Canada. He advises students in Economics and Global Studies (IGS) programs. Grants and funding span health economics, Indigenous well-being, and sustainable energy systems. Collaborations include interdisciplinary teams in health administration and environmental policy. Labs/Teams: Engaged with UBC's Okanagan Sustainability Initiatives and Dalhousie's Health Economics Research Group. Affiliated with professional organizations like the American Economic Association and Canadian Health Economics Study Group.

• Pharmacology
• Traditional Chinese Medicine
• Cancer Therapy
• +۷ مورد دیگر

Wing Lam is an Associate Research Scientist in the Department of Pharmacology at the Yale School of Medicine. He holds a BSc in Molecular Biology and a PhD in Biochemical Pharmacology from City University of Hong Kong, followed by postdoctoral training at Yale. His research focuses on developing traditional Chinese medicine (TCM) formulations as adjuvants for cancer therapy, notably YIV-906, which enhances chemotherapy efficacy and mitigates intestinal toxicity. Lam also pioneered the STAR database for herbal drug discovery and the Mechanism-Based Quality Control (MBQC) platform for botanical drug standardization. Education: BSc (Hons) Molecular Biology, City University of Hong Kong, 1995 PhD Biochemical Pharmacology, City University of Hong Kong, 1999 Postdoc, Pharmacology, Yale University, 1999-2002 His research interests span cancer pharmacology, TCM modernization, and mitochondrial toxicity mechanisms. Key projects include YIV-906’s role in enhancing anti-PD1 and CAR T-cell therapies, developing L-nucleoside analogs like troxacitabine, and investigating tylophorine analogs’ antitumor effects. Lam has co-chaired sessions at multiple Consortium for Globalization of Chinese Medicine (CGCM) meetings and contributed to patents on herbal drug formulations and quality control methods. Recent work explores YIV-906’s potential for inflammatory bowel disease (IBD) and phase II clinical trials for colon and liver cancers. Lam’s publications highlight synergistic drug interactions, mitochondrial DNA depletion mechanisms, and TCM’s evidence-based application in chronic diseases. His grants include studies on PHY906 as an adjuvant in rectal cancer therapy and collaborations with Yiviva, Inc. He maintains active roles in editorial boards, including a special issue on herbal drug quality control in Frontiers in Pharmacology . Lam’s lab is embedded within Dr. Yung-Chi Cheng’s group, focusing on translational pharmacology and botanical drug innovation.

• Nanomedicine
• Therapeutic Targeting
• Drug Delivery Systems
• +۴ مورد دیگر

Dr. Susan Hua is an Associate Professor at the University of Newcastle's School of Biomedical Sciences and Pharmacy, specializing in translational nanopharmaceutics and therapeutic targeting. She established the first translational nanopharmaceutics laboratory in the Hunter region, focusing on drug delivery systems for gastrointestinal, musculoskeletal, and reproductive pathologies. Education: Bachelor of Pharmacy with Honours, University of Queensland (UQ) PhD in Neuroscience and Nanotechnology, UQ Research Interests: Her work centers on using nanotechnology to create targeted drug delivery systems for diseases such as chronic pain, inflammatory conditions, and obstetric complications. Key focuses include oxytocin receptor-targeted liposomes for uterine therapies and localized drug delivery to bypass biological barriers. Awards & Recognition: 2020 DVC(A) Educator Innovation Award 2017 NSW Premier's Early Career Researcher of the Year 2015 HMRI Early Career Researcher of the Year Grants & Collaborations: A/Prof Hua has secured over $5.5M in grants, including NHMRC and ARC funding. She collaborates with institutions like HMRI, John Hunter Hospital, and global teams on projects like nanoparticle-based treatments for preterm labor and uterine hemorrhage. Teaching & Leadership: She coordinates pharmacy programs, emphasizing clinical application and innovation. Her courses include Pharmacotherapeutics and Pharmacy Practice, with awards for teaching excellence (2020, 2011). Labs & Programs: Head of Therapeutic Targeting Program, University of Newcastle Director, Translational Pharmaceutics & Medical Technologies Theme (HMRI)

Aaron Loganمشاهده پروفایل

دانشیار بالینی

• Hematology
• Oncology
• Immunology
• +۳ مورد دیگر

Dr. Aaron Logan is a Clinical Associate Professor of Medicine at the University of California, San Francisco (UCSF). He specializes in the clinical management of acute leukemias, myelodysplastic syndromes, aplastic anemia, and hemophagocytic lymphohistiocytosis. Additionally, he directs a research laboratory focused on immune repertoire profiling following hematopoietic cell transplantation. MD and PhD in Molecular Microbiology and Immunology from Keck School of Medicine (2006) MPhil in History of Medicine from University of Cambridge (2005) Internal Medicine Residency and Hematology Fellowship at Stanford University Dr. Logan's research explores clonotypic diversity in B and T lymphocyte repertoires, utilizing techniques like TREC/KREC quantification, high-throughput sequencing, and mixed lymphocyte reactions. His work has significant applications in tracking immune responses post-transplantation and quantifying measurable residual disease in lymphoid cancers. Notable scientific contributions include advancements in CAR T-cell therapy and immune profiling for blood malignancies. His publications cover topics in B-cell ALL , AML , and measurable residual disease monitoring. 2020 - UCSF Hematology-Oncology Fellowship Teaching Award 2011 - ASH Abstract Award and Research Training Award 2003 - Keck School of Medicine Outstanding Teaching Award As director of the UCSF Hematologic Malignancies Tissue Bank, Dr. Logan provides deidentified patient samples to support collaborative research on blood cancers and post-transplantation immune dynamics.

Peter A. Jonesمشاهده پروفایل

استاد

• Epigenetics
• DNA methylation
• Cancer epigenetics
• +۷ مورد دیگر

Peter A. Jones is President and Chief Scientific Officer at the Van Andel Institute (VAI) in Grand Rapids, Michigan, where he leads the Department of Epigenetics. He previously served as Director of the USC Norris Comprehensive Cancer Center from 1993 to 2011 and has been a central figure in advancing epigenetics research, particularly in cancer. His laboratory investigates DNA methylation, chromatin dynamics, and epigenetic therapies. Research Interests: Dr. Jones's work centers on epigenetic mechanisms in cancer, including DNA methylation, histone modifications, nucleosome positioning, and the therapeutic potential of epigenetic drugs. His research has pioneered the use of DNA methylation inhibitors like 5-azacytidine and explored viral mimicry as a mechanism for immune activation in cancer. He also studies transposable elements and their role in gene regulation and immune response. Publication Trends: His recent publications (2021–2024) reveal a strong focus on the interplay between epigenetics and immunotherapy, particularly how DNA methyltransferase inhibitors (DNMTi) induce viral mimicry, enhance immune recognition, and improve responses to checkpoint blockade. Studies span hematological malignancies, solid tumors, and T cell biology, with frequent collaboration with Stephen Baylin and others. Scientific Awards: Member, National Academy of Sciences Member, National Academy of Medicine Fellow, AACR Academy Fellow, AAAS Fellow, American Academy of Arts and Sciences Kirk A. Landon Award for Basic Cancer Research (2009) Medal of Honor, American Cancer Society (2011) Outstanding Investigator Grant, NCI Harvey Prize (2024) Advising and Grants: Dr. Jones mentors multiple postdoctoral fellows, graduate students, and research scientists. His lab is supported by major grants, including the VAI-SU2C Epigenetics Dream Team, which has launched 15 clinical trials. He has received sustained funding from the National Cancer Institute and collaborates with institutions worldwide to advance epigenetic therapies. Labs and Teams: He leads the Peter Jones Laboratory at VAI, a multidisciplinary team investigating epigenetic regulation in cancer. The lab includes computational biologists, clinical researchers, and molecular biologists, working on both basic mechanisms and translational applications. The team is part of larger collaborative initiatives such as the VAI-SU2C Epigenetics Dream Team and the International Linked Clinical Trials Program.

John Capobiancoمشاهده پروفایل

استاد

• Nanoscience
• Inorganic Chemistry
• Materials Science
• +۷ مورد دیگر

John Capobianco, PhD, is a Professor in the Department of Chemistry and Biochemistry at Concordia University and holds the Honorary Concordia University Research Chair in Nanoscience. His research focuses on lanthanide-doped nanoparticles, upconversion luminescence, and biomedical applications. PhD, University of Geneva Key research areas include: Nanomaterials synthesis and spectroscopy Upconversion for biomedical imaging Drug delivery systems Photodynamic therapy for cancer treatment Optical thermometry and sensing Recent publications highlight advancements in: X-ray detection via photochromic nanoparticles Lipid-coated nanoparticles for lung permeation Cooperative energy transfer in Yb3+/Eu3+ complexes Biocompatible nanomaterials for secure information storage Pr3+-doped radiosensitizers for glioblastoma therapy Scientific recognitions: Honorary Concordia University Research Chair in Nanoscience Teaching includes undergraduate and graduate courses in inorganic chemistry and spectroscopy. His work bridges fundamental material science with applied biomedical engineering, emphasizing optical properties and therapeutic applications of lanthanide-based nanomaterials.

Marc Schneiderمشاهده پروفایل

استاد

• Colloidal drug delivery systems
• Nanoparticle and microparticle engineering
• Nanotechnology in pharmacy
• +۳ مورد دیگر

Prof. Dr. Marc Schneider holds a professorship in Biopharmaceutics and Pharmaceutical Technology at Saarland University's College of Pharmacy . His research focuses on colloidal drug delivery systems, particularly nanostructured and non-spherical particle engineering for overcoming biological barriers in pulmonary and transdermal applications. He leads an internationally recognized lab in Saarbrücken, collaborating with Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) and trinational institutions. Research Highlights: Development of inhalable nano/microparticle systems Surface modification of gelatin nanoparticles Characterization of mucus-penetrating particles 3D printing for microneedle fabrication Atomic Force Microscopy (AFM) for nanoparticle analysis Selected Scientific Awards: European Journal of Pharmaceutics and Biopharmaceutics Best Paper Award (2018) for mucus-penetrating nanoparticles Recognized in 'Ausgezeichnete Orte im Land der Ideen' competition (2018) for 'Nano-Mais' drug delivery system Collaborative Networks: Co-editor for Advanced Drug Delivery Reviews special issue on biological barriers Key participant in trinational Master's program in Biomedicine with Strasbourg, Mainz, and Luxembourg Active in Controlled Release Society (CRS) conferences and local chapters

Allan Davidمشاهده پروفایل

استاد

• Smart Materials
• Nanomedicine
• Cancer Research
• +۴ مورد دیگر

Allan David serves as the John W. Brown Professor of Chemical Engineering and Associate Dean for Research at Auburn University's Samuel Ginn College of Engineering. His leadership extends across academic administration and cutting-edge nanomedicine research, with a focus on translating laboratory discoveries into clinical applications. His educational foundation includes: Ph.D. in Chemical Engineering, University of Maryland B.S. in Chemical Engineering, University of Maryland Dr. David's research program pioneers nanomedicine applications through the development of smart materials for cancer diagnostics and therapy. His work spans nanoparticle-based MRI contrast agents , ocular drug delivery systems , and vaccine delivery platforms , with particular emphasis on optimizing physicochemical properties for targeted biological interactions. Current projects address critical healthcare challenges including safer contrast agents for patients with kidney impairment and precision cancer targeting mechanisms. Analysis of his 15 most recent publications reveals a cohesive research trajectory centered on magnetic nanoparticles and biomimetic delivery systems . The work demonstrates increasing translational focus, evolving from fundamental nanoparticle characterization (2020-2021) to clinically relevant applications like ocular delivery and cancer theranostics (2022-2024), culminating in commercialization efforts through NanoXort, LLC. Dr. David has secured significant research funding including an $184,773 grant from the Alabama Department of Economic and Community Affairs (ADECA) for developing cardiovascular MRI agents. He leads collaborative efforts that bridge chemical engineering with biomedical innovation, notably co-founding NanoXort, LLC to commercialize safer MRI contrast agents addressing gadolinium toxicity concerns for renal-impaired patients. His laboratory operates at the intersection of chemical engineering and medicine, focusing on nanoparticle-cell interactions and targeted delivery systems. The research group maintains strong industry partnerships through the NanoXort startup, which has secured $1 million NSF funding to advance MRI contrast agent technology toward clinical implementation.

Joseph Wangمشاهده پروفایل

استاد

• Nanomachines
• Wearable Sensors
• Electrochemistry
• +۵ مورد دیگر

Dr. Joseph Wang is the Distinguished Professor of Nanoengineering and the SAIC Endowed Chair at UC San Diego. He leads the NBE Lab and directs the Center of Wearable Sensors and the Center for Mobile-health Systems. With over 50 researchers in his team, his work focuses on nanomachines, wearable sensors, electrochemistry, and analytical chemistry. His global citation ranking places him #13 in Chemistry and #31 in Materials Science, with an H-index of 217 and over 180,000 citations. He has been a Highly Cited Researcher since 2014 and ranks #4 in Nanoscience & Nanotechnology in the 2025 World Top 100 Scientists list. His research has led to groundbreaking innovations, including microrobots for lung cancer treatment, multiplexed microneedle sensors, and wearable devices for real-time health monitoring. He has been honored with prestigious awards such as the 2024 ACS Award in Analytical Chemistry, IEEE Sensors Council Award, and IUPAC Medal. He holds honorary doctorates from Comenius University and Charles University, and Woxsen University named its Chemistry Department after him. Key contributions include pioneering work in biohybrid microrobots, self-healing wearable devices, and sweat-based health monitoring systems. His lab’s work has been featured in Nature, Science, and The Economist. He co-authored influential books like Analytical Electrochemistry (4th ed.) and Nanomachines , and his research spans clinical applications, environmental sensing, and personalized medicine.

Yeonhwa Parkمشاهده پروفایل

استاد

• Functional Foods
• Obesity
• Environmental Contaminants
• +۳ مورد دیگر

Yeonhwa Park is a Professor and holder of the Francis Chair in the Department of Food Science at the University of Massachusetts Amherst. Her research focuses on functional foods, bioactive components, and environmental contaminants' effects on obesity and aging. She investigates food bioactives like conjugated linoleic acid (CLA) and environmental pollutants like PFAS to understand their roles in metabolic disorders and aging mechanisms. Her work spans multiple models, including C. elegans, zebrafish, and rodent studies, emphasizing translational applications for human health. Teaching responsibilities include courses such as 'Science of Food' (FS150), 'Biology of Food in Human Health' (FS270), and 'Bioactive Food Components' (FS750). Awards include Clarivate Highly Cited Researcher (2017–2018), Faculty Convocation Award (2015), and the Timothy Mounts Award (2015). Her research has been published in over 150 peer-reviewed articles, with recent emphasis on environmental contaminants' impact on obesity and type 2 diabetes, and the use of C. elegans for screening bioactives. Key findings include CLA's role in fat reduction, PFAS-induced metabolic disruption, and the application of alternative models (e.g., C. elegans) to reduce animal testing. Her lab integrates molecular biology, toxicology, and food science to address global health challenges like the obesity epidemic and environmental toxin exposure.

• Metal-Organic Frameworks (MOFs)
• Nanoparticles
• Gold nanoparticles
• +۶ مورد دیگر

Jia Min Chin is an Associate Professor at the Faculty of Chemistry , affiliated with the Institute of Functional Materials and Catalysis . Her research focuses on advanced materials, particularly Metal-Organic Frameworks (MOFs), Gold nanoparticles, and N-Heterocyclic Carbene (NHC) chemistry, with applications in catalysis, environmental remediation, and sustainable technology. Her scientific work contributes to United Nations Sustainable Development Goals (SDGs) through innovations in functional materials and catalytic systems. Key projects include Breaking the ice – novel energy efficient hybrid de-icing systems and DYNAMOF: Electric Field Assisted Dynamic MOF Alignment , funded by major research grants. She received the prestigious ERC Grant in 2020 for her contributions to materials science. Chin's research spans MOF-based nanocomposites, photonic assemblies, and biomedical applications. Her publications highlight trends in Stimuli-responsive materials (electric/magnetic fields) Green catalytic systems Anti-icing and humidity-sensing coatings Cancer therapy platforms Scientific Awards ERC Grant (2020) She collaborates globally on cutting-edge topics like MOF alignment, nerve agent decomposition, and CO2 reduction, with recent activities including lectures at international conferences and workshops on material structuring.

Jennifer Kaiserمشاهده پروفایل

دانشیار

• Environmental Engineering
• Atmospheric Chemistry
• Volatile Organic Compounds (VOCs)
• +۳ مورد دیگر

Jennifer Kaiser is an Associate Professor at Georgia Institute of Technology, affiliated with the School of Civil and Environmental Engineering and Earth and Atmospheric Sciences . Her research focuses on air pollutant formation, particularly volatile organic compounds (VOCs), and their impacts on air quality and climate. Endowed Position: Greene Early Career Professor (2024) Key Projects: Emissions from agriculture/oil-gas, biosphere-atmosphere interactions, satellite data validation Tools: CMAQ modeling, TROPOMI satellite analysis, low-cost sensor networks Her work spans instrument development to global chemistry-transport modeling, with recent emphasis on satellite-based monitoring and health risk assessment. She leads the Kaiser Group , which investigates VOC dynamics in urban and wildfire-affected regions. Scientific Awards: NOAA Grant (2021) Greene Early Career Professor (2024) Contact: jennifer.kaiser@ce.gatech.edu | Office: Ford Environmental Science & Technology Building, Room 3224

• Polymer Science
• Inorganic Chemistry
• Nanotechnology
• +۷ مورد دیگر

Ulrich B. Wiesner is the Spencer T. Olin Professor of Engineering at Cornell University since 2008, with a career spanning over two decades in polymer-inorganic hybrid nanomaterials. His work bridges materials science, chemistry, and biomedical engineering, focusing on block copolymer self-assembly for multifunctional materials. Education: Diploma in Chemistry (University of Mainz, 1988), Ph.D. in Physical Chemistry (University of Mainz & MPI-P, 1991) Research Interests center on combining soft polymeric materials with inorganic/solid-state chemistry to create hierarchical hybrid materials. Key areas include: Energy conversion and storage via mesoporous oxides/non-oxides Clean water technologies through advanced materials Nanomedicine applications in cancer therapy and bioimaging Development of C-dots: ultrasmall fluorescent silica nanoparticles Structure-directing agents from dendron architectures His article trends reveal a focus on asymmetric porous structures (2024-2025), 3D-printed quantum materials (2024), and biomedical applications of C-dots for super-resolution microscopy and targeted drug delivery (2023-2025). Scientific Awards include: National Academy of Inventors Fellow (2024) "Ambassadeur pour la Chimie Française" (2019) Arthur K. Doolittle Award (2016) ACS PMSE Fellow (2015) NSF Creativity Award (2008) Cornell Teaching Excellence Award (2005) IBM Faculty Partnership Award (2001) Carl Duisberg Memorial Award (1999) As co-director of the MSKCC-Cornell Center for Translation of Cancer Nanomedicine (2015-present), he leads interdisciplinary teams developing clinical nanoparticle probes. His work has produced >250 peer-reviewed publications and numerous patents, with recent breakthroughs in antibody fragment-nanoparticle therapeutics for gastric cancer eradication.

Lion Shahabمشاهده پروفایل

استاد

• Health Psychology
• Tobacco Control
• Behavioral Science
• +۱۳ مورد دیگر

Lion Shahab is a Professor of Health Psychology at University College London (UCL) , where he leads the Research Department of Behavioural Science and Health . His work focuses on smoking cessation , e-cigarette impact , tobacco control policy , and behavioral science in public health. Education: MA in Psychology, Philosophy, and Physiology (University of Oxford, 2003) MSc in Health Psychology (King’s College London, 2004) PhD in Health Psychology (University of London, 2008) MSc in Neuroscience (UCL, 2010) Stage II Health Psychology Qualification (UCL, 2012) Research Interests include biomarker feedback for behavior change, nicotine product regulation, smoking-related diseases, novel cessation interventions, and the interplay between nicotine use and mental health. His methods span human trials, epidemiology, and animal electrophysiology studies. Articles Trends highlight his focus on vaping epidemiology , smoking cessation pharmacology , and public health policy modeling . Recent work addresses the long-term impact of e-cigarettes, secondhand exposure risks, and regulatory strategies. Scientific Awards : Fellow of the Society for Research on Nicotine and Tobacco (2023) Fellow of the British Psychological Society (2023) Seelye Visiting Fellow at the University of Auckland (2024) He supervises MSc and PhD students and co-directs the UCL Tobacco and Alcohol Research Group . His editorial roles include Deputy Editor at Nicotine & Tobacco Research and Senior Editor at Addiction .

Natalie Johnsonمشاهده پروفایل

دانشیار

• Environmental Toxicology
• Air Pollution Health Effects
• Developmental Biology
• +۴ مورد دیگر

Natalie Johnson is an Associate Professor in Environmental and Occupational Health at the College of Veterinary Medicine, Texas A&M University. She chairs the Interdisciplinary Program in Toxicology and leads critical research on air pollution impacts on vulnerable populations. Education PhD in Toxicology, Texas A&M University College of Veterinary Medicine Postdoctoral Fellowship in Environmental Health Sciences, Johns Hopkins Bloomberg School of Public Health BS in Biology, Texas A&M University College of Science Her research focuses on inhalation toxicology , maternal exposure to pollutants , and gene-environment interactions . She directs the mobile responding to air pollution in disasters (mRAPiD van), a real-time chemical pollutant detection platform, and investigates emerging environmental chemicals in breast milk. Current projects include: Respiratory toxicology of inhaled pollutants Prenatal/pediatric air pollution exposure and immune development Development of green-engineered clays for toxin mitigation